POLYSAN Scientific & Technological Pharmaceutical Company
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 5/1/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (13)
Cytoflavin in the Complex Rehabilitation of Stroke Patients
Started: 6/30/2023
Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza
Started: 9/15/2023
International Trial of Efficacy of Cytoflavin in Head Trauma
Started: 11/22/2020
Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery
Started: 6/2/2017
Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy
Started: 11/25/2020
Remaxol® in Mechanical Jaundice of Non-malignant Origin
Started: 4/3/2017
REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis
Started: 5/1/2025
Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis
Started: 5/27/2023
Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients
Started: 6/16/2021
"Unifuzol®" in Patients With Peripheral Arterial Disease
Started: 3/16/2018
Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
Started: 5/30/2016
Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers
Started: 7/15/2016